その他のCD抗体薬(抗CD30抗体薬,抗CD33抗体薬,抗CD52抗体薬) (特集がん分子標的薬の効果と副作用 : 期待される効果と評価 ; 抗体薬)

その他のCD抗体薬(抗CD30抗体薬,抗CD33抗体薬,抗CD52抗体薬)

(特集がん分子標的薬の効果と副作用 : 期待される効果と評価 ; 抗体薬)

Journal name: 日本臨床 = Japanese journal of clinical medicine 75(9)=1127:2017.9

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

CiNii Research
Search Service
You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Check the holdings of this book

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 記事
Title: その他のCD抗体薬(抗CD30抗体薬,抗CD33抗体薬,抗CD52抗体薬)
Author/Editor: 薄井紀子
Series Title: 特集がん分子標的薬の効果と副作用 : 期待される効果と評価 ; 抗体薬
Author Heading: 薄井紀子
Alternative Title: Current treatment for hematological malignancies with anti-CD (anti-CD30, anti-CD33, and anti-CD52) monoclonal antibodies
Periodical title: 日本臨床 = Japanese journal of clinical medicine
No. or year of volume/issue: 75(9)=1127:2017.9
Volume: 75
Issue: 9
Sequential issue number: 1127
Pages: 1324-1331
Publication date of volume/issue (W3CDTF): 2017-09
ISSN (Periodical Title): 0047-1852
ISSN-L (Periodical Title): 0047-1852
Publication (Periodical Title): 東京 : 日本臨床社
Place of Publication (Country Code): JP
Text Language Code: jpn
Subject Heading: brentuximab vedotin
gemtuzumab ozogamicin
alemtuzumab
antibody drug conjugate
NDLC: ZS7
Target Audience: 一般
Holding library: 国立国会図書館
Call No.: Z19-226
Data Provider (Database): 国立国会図書館 : 国立国会図書館雑誌記事索引
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 028497444
http://id.ndl.go.jp/bib/028497444
Bibliographic Record Category (NDL): 632